INTERNATIONAL STEM CELL CORPORATION PROMISSORY NOTE
Exhibit 10.1
INTERNATIONAL STEM CELL CORPORATION
PROMISSORY NOTE
FOR VALUE RECEIVED, and subject to the terms and conditions set forth herein, on this 9th day of March, 2016 (the Issuance Date), International Stem Cell Corporation, a Delaware corporation (the Borrower), hereby unconditionally promises to pay to the order of Andrey Semechkin or his assigns (the Noteholder), the principal amount of three million eight hundred ten thousand dollars ($3,810,000) (the Loan), together with all accrued interest thereon, as provided in this Promissory Note (the Note).
1. Previous Loan. On January 8, 2016 Noteholder was issued a Promissory Note in the principal amount of $3,810,000 by the Borrower (the Original Note). The Noteholder and the Borrower have agreed to revise the Original Note to extend the maturity date set forth therein to April 10, 2016. For ease of administration, the Noteholder has surrendered the Original Note, in return for which the Noteholder was issued this Note, reflecting the revised terms of the Loan.
2. Final Payment Date; Optional Prepayments.
2.1 Final Payment Date. The aggregate unpaid principal amount of the Loan and all accrued and unpaid interest shall be due and payable April 10, 2016 (the Maturity Date).
2.2 Optional Prepayment. The Borrower may prepay the Loan in whole or in part at any time or from time to time without penalty or premium by paying the principal amount to be prepaid together with accrued interest thereon to the date of prepayment. No prepaid amount may be reborrowed.
3. Interest.
3.1 Interest Rate. The outstanding principal amount of the Loan made hereunder shall bear interest at the annual rate of One-Half of One Percent (0.50%) from the date the Loan was made until the Loan is paid in full, whether at maturity, by prepayment or otherwise.
3.2 Interest Payment Dates. Interest shall be payable on maturity, or earlier with respect to any prepayment.
3.3 Computation of Interest. All computations of interest shall be made on the basis of a year of 360 days and the actual number of days elapsed. Interest shall accrue on the Loan on the day on which such Loan is made, and shall not accrue on the Loan (or any portion thereof) for the day on which it is paid.
3.4 Interest Rate Limitation. If at any time and for any reason whatsoever, the interest rate payable on the Loan shall exceed the maximum rate of interest permitted to be charged by the Noteholder to the Borrower under applicable law, such interest rate shall be reduced automatically to the maximum rate of interest permitted to be charged under applicable law, and that portion of any sum paid attributable to that portion of such interest rate that exceeds the
maximum rate of interest permitted by applicable law shall be deemed a voluntary prepayment of principal.
4. Payment Mechanics. All payments of principal and interest shall be made in lawful money of the United States of America by check or by wire transfer of immediately available funds to the Noteholders account at a bank specified by the Noteholder in writing to the Borrower from time to time.
5. Governing Law. This Note and any claim, controversy, dispute or cause of action based upon, arising out of or relating to this Note, and the transactions contemplated hereby, shall be governed by the laws of the State of California.
IN WITNESS WHEREOF, the Borrower has executed this Note as of the Issuance Date written above.
BORROWER | NOTEHOLDER | |||
International Stem Cell Corporation | Andrey Semechkin | |||
|
| |||
Signature | Signature | |||
Mahnaz Ebrahimi | ||||
Chief Financial Officer |